SBLENDORIO GLENN

CIK 00012774787 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001277478

Recent Transactions

50 trades

Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2026-06-17+50,000→ 50,000 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−20,000→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−74,872→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2026-04-27$14.50/sh−142,564→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−42,467→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−19,473→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−45,423→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−36,111→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−30,474→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−16,236→ 0 total
Disposition to Issuer
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2026-04-27−18,574→ 0 total
Award
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-19+6,200→ 6,200 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-19+8,300→ 8,300 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2026-01-05+45,000→ 45,000 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2025-06-05+20,414→ 115,857 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2025-06-05+74,872→ 74,872 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-02-13+32,900→ 32,900 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2024-06-06+11,847→ 95,443 total
Award
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2024-06-06+42,467→ 42,467 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2024-05-22+22,000→ 22,000 total
Exercise/Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Stock Options (right to buy)
2024-03-07−15,000→ 0 total
Exercise/Conversion
AMICUS THERAPEUTICS, INC.$FOLD
Common Stock
2024-03-07$2.80/sh+15,000→ 83,596 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−551→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,748→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,036→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,174→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,089→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,790→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,598→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−8,111→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,966→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,547→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−1,750→ 0 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−23,447→ 0 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-09-13+44,000→ 44,000 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−7,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−300,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Common Stock
2023-07-11−239,275→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−260,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−252,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−6,949→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−15,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Restricted Stock Units
2023-07-11−94,500→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−293,150→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Restricted Stock Units
2023-07-11−23,750→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Restricted Stock Units
2023-07-11−73,315→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−190,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−325,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−150,000→ 0 total
Disposition to Issuer
IVERIC bio, Inc.
Stock Option (Right to Buy)
2023-07-11−133,500→ 0 total

Companies

Recent Filings

Address

C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455

EMERYVILLE, CA, 94608

View on SEC.gov